Cell And Gene Therapy Global Market Opportunities And Strategies To 2035

Description

Cell and gene therapy is a branch of advanced medicine that involves modifying or using living cells and genetic material to treat, prevent, or potentially cure diseases. Cell therapy works by introducing healthy or engineered cells into a patient to replace or repair damaged tissues, while gene therapy involves altering, replacing, or regulating genes within a patient's cells to correct genetic disorders or modify disease pathways. The primary purpose of cell and gene therapy is to address the root cause of diseases rather than just managing symptoms.

The cell and gene therapy market consist of sales by entities (organizations, sole traders and partnerships) of cell and gene therapy products that are used by healthcare providers, including hospitals and specialty care centers, for patients with complex, chronic, or life-threatening conditions such as cancers, inherited genetic disorders, and degenerative diseases. The therapies are typically administered in controlled clinical settings by trained medical specialists during specific treatment episodes when conventional treatments have proven ineffective or when a curative approach is medically indicated.

The global cell and gene therapy market was valued at $5,556.5 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 23.00%.

Shift Toward Personalized And Precision Medicine

The shift toward personalized and precision medicine supported the growth of the cell and gene therapy market in the historic period. Increasing focus on therapies tailored to individual genetic profiles and disease characteristics drove demand for highly targeted and effective solutions. Cell and gene therapies align closely with this paradigm, as they are designed to address diseases at the genetic or cellular level, improving treatment outcomes and minimizing adverse effects. Advances in genomic sequencing, biomarker identification and companion diagnostics further enabled personalized treatment strategies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA granted approval for 16 personalized therapies in 2023 aimed at treating rare diseases, marking a rise from the six such treatments approved in 2022. Therefore, the shift toward personalized and precision medicine drove the growth of the cell and gene therapy market.

Commercialization Of Allogeneic Cell Therapy For Chronic Osteoarthritis Treatment

Companies operating in the cell and gene therapy market are focusing on commercializing clinically validated, allogeneic cell therapies through strategic partnerships to deliver scalable, disease-modifying treatments for high-prevalence chronic conditions. For instance, in December 2025, Cipla Limited, an India-based pharmaceutical company, partnered with Stempeutics Research, an India-based life science company to launch Ciplostem, an allogeneic mesenchymal stromal cell therapy for Grade II and III knee osteoarthritis, approved by India's drug regulator. The single-dose intra-articular treatment uses bone-marrow-derived MSCs combined with hyaluronic acid to reduce inflammation, relieve pain and preserve cartilage. Designed as a disease-modifying therapy, Ciplostem addresses limitations of conventional symptomatic treatments. Backed by Phase 3 clinical evidence, the launch marks Cipla's entry into orthobiologics and expands access to regenerative, cell-based therapies for millions of osteoarthritis patients in India.

The global cell and gene therapy market is highly concentrated, with large players operating in the market. The top 10 competitors in the market made up 66.6% of the total market in 2024.

Cell And Gene Therapy Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global cell and gene therapy market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for cell and gene therapy? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The cell and gene therapy market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider cell and gene therapy market; and compares it with other markets.

The report covers the following chapters

Introduction And Market Characteristics Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by application and by end user.
Key Trends Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Regional And Country Analysis- historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
Market Segmentation Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by product, by application and by end user in the market. Historic (2020-2025) and forecast (2025-2030) and (2020-2035) market values and growth and market share comparison by region market.
Regional Market Size And Growth - Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies - Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Recent Developments - Information on recent developments in the market covered in the report.
Conclusions And Recommendations This section includes recommendations for cell and gene therapy providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Product: Cell Therapy; Gene Therapy
2) By Application: Oncology; Neurological Disorders; Other Applications
3) By End User: Hospitals; Ambulatory Surgical Centers; Cancer Care Centers; Wound Care Centers; Other End Users
Companies Mentioned: Gilead Sciences.; Novartis AG; Bristol-Myers Squibb Company; Johnson & Johnson; Sarepta Therapeutics
Countries: Australia; China; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; cell and gene therapy indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: PH5MCGTE01_G26Q1

1 Executive Summary

1.1 Cell And Gene Therapy - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Cell And Gene Therapy Market Definition And Segmentations
6.4 Market Segmentation By Product
- 6.4.1 Cell Therapy
- 6.4.2 Gene Therapy
6.5 Market Segmentation By Application
- 6.5.1 Oncology
- 6.5.2 Neurological Disorders
- 6.5.3 Other Applications
6.6 Market Segmentation By End User
- 6.6.1 Hospitals
- 6.6.2 Ambulatory Surgical Centers
- 6.6.3 Cancer Care Centers
- 6.6.4 Wound Care Centers
- 6.6.5 Other End-Users

7 Major Market Trends

7.1 Commercialization Of Allogeneic Cell Therapy For Chronic Osteoarthritis Treatment
7.2 Expansion Of GMP-Grade Gene-Editing Solutions To Accelerate Clinical Development
7.3 Expansion Of Scalable GMP Manufacturing For Advanced Cell And Gene Therapies
7.4 Localized Commercialization Of Personalized CAR-T Therapies To Expand Patient Access
7.5 Automation Of Scalable IPSC-Based Cell Therapy Manufacturing For Neurological Disorders
7.6 Regulatory Approval Of Autologous T-Cell Therapy For Advanced Melanoma
7.7 Strategic Investments To Expand Manufacturing Capacities
7.8 Adoption Of Platform-Agnostic Systems To Streamline Cell And Gene Therapy Delivery
7.9 Strategic Collaborations For Advancing Cancer Treatment Production Processes

8 Global Cell And Gene Therapy Growth Analysis And Strategic Analysis Framework

8.1 Global Cell And Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
- 8.1.1 Political
- 8.1.2 Economic
- 8.1.3 Social
- 8.1.4 Technological
- 8.1.5 Environmental
- 8.1.6 Legal
8.2 Analysis Of End User (B2B)
- 8.2.1 Hospitals
- 8.2.2 Ambulatory Surgical Centers
- 8.2.3 Cancer Care Centers
- 8.2.4 Wound Care Centers
- 8.2.5 Other End Users
8.3 Global Cell And Gene Therapy Market Growth Rate Analysis
8.4 Historic Market Growth, 2020 - 2025, Value ($ Million)
- 8.4.1 Market Drivers 2020 - 2025
- 8.4.2 Market Restraints 2020 - 2025
8.5 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
- 8.6.1 Quantitative Growth Contributors
- 8.6.2 Drivers
- 8.6.3 Restraints
8.7 Global Cell And Gene Therapy Total Addressable Market (TAM)
- 8.7.1 TAM Comparison Analysis

9 Global Cell And Gene Therapy Market Segmentation

9.1 Global Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
9.2 Global Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
9.3 Global Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
9.4 Global Cell And Gene Therapy Market, Sub Segmentation Of Cell Therapy, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
9.5 Global Cell And Gene Therapy Market, Sub Segmentation Of Gene Therapy, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

10 Cell And Gene Therapy Market, Regional and Country Analysis

10.1 Global Cell And Gene Therapy Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
10.2 Global Cell And Gene Therapy Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

11 Asia-Pacific Market

11.1 Summary
11.2 Market Overview
- 11.2.1 Region Information
- 11.2.2 Market Information
- 11.2.3 Background Information
- 11.2.4 Government Initiatives
- 11.2.5 Regulations
- 11.2.6 Regulatory Bodies
- 11.2.7 Major Associations
- 11.2.8 Taxes Levied
- 11.2.9 Corporate Tax Structure
- 11.2.10 Investments
- 11.2.11 Major Companies
11.3 Asia-Pacific Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.4 Asia-Pacific Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.5 Asia-Pacific Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.6 Asia-Pacific Cell And Gene Therapy Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
- 11.9.1 Country Information
- 11.9.2 Market Information
- 11.9.3 Background Information
- 11.9.4 Government Initiatives
- 11.9.5 Regulations
- 11.9.6 Regulatory Bodies
- 11.9.7 Major Associations
- 11.9.8 Taxes Levied
- 11.9.9 Corporate Tax Structure
- 11.9.10 Investments
- 11.9.11 Major Companies
11.10 China Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.11 China Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.12 China Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.13 India Market
11.14 India Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.15 India Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.16 India Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
- 11.19.1 Country Information
- 11.19.2 Market Information
- 11.19.3 Background Information
- 11.19.4 Government Initiatives
- 11.19.5 Regulations
- 11.19.6 Regulatory Bodies
- 11.19.7 Major Associations
- 11.19.8 Taxes Levied
- 11.19.9 Corporate Tax Structure
- 11.19.10 Investment
- 11.19.11 Major Companies
11.20 Japan Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.21 Japan Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.22 Japan Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.23 Australia Market
11.24 Australia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.25 Australia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.26 Australia Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.27 Indonesia Market
11.28 Indonesia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.29 Indonesia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.30 Indonesia Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.31 South Korea Market
11.32 Summary
11.33 Market Overview
- 11.33.1 Country Information
- 11.33.2 Market Information
- 11.33.3 Background Information
- 11.33.4 Government Initiatives
- 11.33.5 Regulations
- 11.33.6 Regulatory Bodies
- 11.33.7 Major Associations
- 11.33.8 Taxes Levied
- 11.33.9 Corporate Tax Structure
- 11.33.10 Investments
- 11.33.11 Major Companies
11.34 South Korea Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.35 South Korea Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11.36 South Korea Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

12 Western Europe Market

12.1 Summary
12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate tax structure
- 12.2.10 Investments
- 12.2.11 Major Companies
12.3 Western Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.4 Western Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.5 Western Europe Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.6 Western Europe Cell And Gene Therapy Market: Country Analysis
12.7 UK Market
12.8 UK Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.9 UK Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.10 UK Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.11 Germany Market
12.12 Germany Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.13 Germany Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.14 Germany Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.15 France Market
12.16 France Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.17 France Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.18 France Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.19 Italy Market
12.20 Italy Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.21 Italy Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.22 Italy Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.23 Spain Market
12.24 Spain Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.25 Spain Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12.26 Spain Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

13 Eastern Europe Market

13.1 Summary
13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate Tax Structure
- 13.2.10 Investments
- 13.2.11 Major Companies
13.3 Eastern Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
13.4 Eastern Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
13.5 Eastern Europe Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
13.6 Eastern Europe Cell And Gene Therapy Market: Country Analysis
13.7 Russia Market
13.8 Russia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
13.9 Russia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
13.10 Russia Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

14 North America Market

14.1 Summary
14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Investments
- 14.2.11 Major Companies
14.3 North America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
14.4 North America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
14.5 North America Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
14.6 USA Market
14.7 Summary
14.8 Market Overview
- 14.8.1 Country Information
- 14.8.2 Market Information
- 14.8.3 Background Information
- 14.8.4 Government Initiatives
- 14.8.5 Regulations
- 14.8.6 Regulatory Bodies
- 14.8.7 Major Associations
- 14.8.8 Taxes Levied
- 14.8.9 Corporate Tax Structure
- 14.8.10 Investments
- 14.8.11 Major Companies
14.9 USA Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
14.10 USA Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
14.11 USA Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
14.12 Canada Market
14.13 Summary
14.14 Market Overview
- 14.14.1 Country Information
- 14.14.2 Market Information
- 14.14.3 Background Information
- 14.14.4 Government Initiatives
- 14.14.5 Regulations
- 14.14.6 Regulatory Bodies
- 14.14.7 Major Associations
- 14.14.8 Taxes Levied
- 14.14.9 Corporate Tax Structure
- 14.14.10 Investments
- 14.14.11 Major Companies
14.15 Canada Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
14.16 Canada Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
14.17 Canada Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

15 South America Market

15.1 Summary
15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Investments
- 15.2.11 Major Companies
15.3 South America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
15.4 South America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
15.5 South America Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
15.6 South America Cell And Gene Therapy Market: Country Analysis
15.7 Brazil Market
15.8 Brazil Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
15.9 Brazil Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
15.10 Brazil Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 Middle East Market

16.1 Summary
16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Investments
- 16.2.11 Major Companies
16.3 Middle East Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
16.4 Middle East Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
16.5 Middle East Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 Africa Market

17.1 Summary
17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Investments
- 17.2.11 Major Companies
17.3 Africa Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
17.4 Africa Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
17.5 Africa Cell And Gene Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 Competitive Landscape And Company Profiles

18.1 Company Profiles
18.2 Gilead Sciences
- 18.2.1 Company Overview
- 18.2.2 Products And Services
- 18.2.3 Business Strategy
- 18.2.4 Financial Overview
18.3 Novartis AG.
- 18.3.1 Company Overview
- 18.3.2 Products And Services
- 18.3.3 Financial Overview
18.4 Bristol-Myers Squibb Company
- 18.4.1 Company Overview
- 18.4.2 Products And Services
- 18.4.3 Financial Overview
18.5 Johnson & Johnson
- 18.5.1 Company Overview
- 18.5.2 Products And Services
- 18.5.3 Financial Overview
18.6 Sarepta Therapeutics
- 18.6.1 Company Overview
- 18.6.2 Products And Services
- 18.6.3 Business Strategy
- 18.6.4 Financial Overview

19 Other Major And Innovative Companies

19.1 Vertex Pharmaceuticals Incorporated
- 19.1.1 Company Overview
- 19.1.2 Products And Services
19.2 CSL Limited
- 19.2.1 Company Overview
- 19.2.2 Products And Services
19.3 Krystal Biotech
- 19.3.1 Company Overview
- 19.3.2 Products And Services
19.4 F. Hoffmann-La Roche AG (Spark Therapeutics)
- 19.4.1 Company Overview
- 19.4.2 Products And Services
19.5 Amgen Inc.
- 19.5.1 Company Overview
- 19.5.2 Products And Services
19.6 Iovance Biotherapeutics
- 19.6.1 Company Overview
- 19.6.2 Products And Services
19.7 Genetix Biotherapeutics (Formerly Bluebird Bio)
- 19.7.1 Company Overview
- 19.7.2 Products And Services
19.8 Ferring Pharmaceuticals A/S
- 19.8.1 Company Overview
- 19.8.2 Products And Services
19.9 PTC Therapeutics
- 19.9.1 Company Overview
- 19.9.2 Products And Services
19.10 CRISPR Therapeutics AG
- 19.10.1 Company Overview
- 19.10.2 Products And Services
19.11 uniQure NV
- 19.11.1 Company Overview
- 19.11.2 Products And Services
19.12 Autolus Therapeutics
- 19.12.1 Company Overview
- 19.12.2 Products And Services
19.13 Orchard Therapeutics plc.
- 19.13.1 Company Overview
- 19.13.2 Products And Services
19.14 Mesoblast Limited
- 19.14.1 Company Overview
- 19.14.2 Products And Services
19.15 Adaptimmune Therapeutics
- 19.15.1 Company Overview
- 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

22.1 NKGen Biotech Inc. Acquired NKMax Co. Ltd.
22.2 AstraZeneca plc Acquired EsoBiotec B.V.
22.3 Roche AG Acquired Poseida Therapeutics Inc.
22.4 NAYA Biosciences Inc Acquired Florida Biotechnologies Inc.
22.5 QHP Capital Acquired Applied StemCell Inc.

23 Recent Development

23.1 Breakthrough In Base-Edited Cell Therapy For Treatment-Resistant Leukemia
23.2 Regulatory Approval Of A Novel Cellular Therapy For Severe Aplastic Anemia
23.3 Expansion Of GMP-Certified Manufacturing For Cell And Gene Therapies
23.4 Launch Of Indigenous CAR-T Therapy To Advance Cancer Treatment Access

24 Opportunities And Strategies

24.1 Global Cell And Gene Therapy Market In 2030 - Countries Offering Most New Opportunities
24.2 Global Cell And Gene Therapy Market In 2030 - Segments Offering Most New Opportunities
24.3 Global Cell And Gene Therapy Market In 2030 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Cell And Gene Therapy Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer